Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.55563/clinexprheumatol/beucf1 http://scihub22266oqcxt.onion/10.55563/clinexprheumatol/beucf1 34238403!ä!34238403 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Exp+Rheumatol 2021 ; 39 (4): 705-720 Nephropedia Template TP {{tp|p=34238403|t=2021. One year in review 2021: novelties in the treatment of rheumatoid arthritis |pdf=|usr=}}{{34238403}} gab.com Text One year in review 2021: novelties in the treatment of rheumatoid arthritis JO: Clin Exp Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=34238403 #FOAvip Management of rheumatoid arthritis (RA) has evolved over the years as a result of better understanding of the role of different therapeutic strategies, as well as following an increasing availability of new disease-modifying antirheumatic drugs. However, the role of patients in sharing decisions, as well as the rules informing precision medicine or the principles to follow in case of specific comorbidities or extra-articular manifestations are still areas for improvement. Moreover, in 2020, the novel Coronavirus disease-19 outbreak has completely changed many attitudes in terms of assessment and treatment paradigms in most clinical diseases, including RA. In this narrative review, the authors report their specific point of view on the management of RA, based on a critical revision of literature published in 2020, focusing on relevant novelties and future research directions. Twit Text FOAVip One year in review 2021: novelties in the treatment of rheumatoid arthritis ????Clin Exp Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=34238403 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34238403 #FOAvip English Wikipedia <ref>{{Cite pmid|34238403}}</ref> One year in review 2021: novelties in the treatment of rheumatoid arthritis #MMPMID34238403 Silvagni E; Sakellariou G; Bortoluzzi A; Giollo A; Ughi N; Vultaggio L; Scire CA Clin Exp Rheumatol 2021[Jul]; 39 (4): 705-720 PMID34238403show ga Management of rheumatoid arthritis (RA) has evolved over the years as a result of better understanding of the role of different therapeutic strategies, as well as following an increasing availability of new disease-modifying antirheumatic drugs. However, the role of patients in sharing decisions, as well as the rules informing precision medicine or the principles to follow in case of specific comorbidities or extra-articular manifestations are still areas for improvement. Moreover, in 2020, the novel Coronavirus disease-19 outbreak has completely changed many attitudes in terms of assessment and treatment paradigms in most clinical diseases, including RA. In this narrative review, the authors report their specific point of view on the management of RA, based on a critical revision of literature published in 2020, focusing on relevant novelties and future research directions. |*Antirheumatic Agents/adverse effects[MESH] |*Arthritis, Rheumatoid/diagnosis/drug therapy/epidemiology[MESH] |*COVID-19[MESH] |Comorbidity[MESH] |Humans[MESH]One year in review 2021: novelties in the treatment of rheumatoid arth(epmc).pdf DeepDyve Pubget Overpricing